Literature DB >> 30955510

Pulmonary Hypertension.

Darlene Kim1, M Patricia George2.   

Abstract

Pulmonary hypertension (PH) is a chronic and progressive disease that presents like many other lung diseases, often leading to a delay in diagnosis, and therefore a delay in optimal therapy. This article provides a review of PH for internists, covering clinical presentation, diagnostic algorithm, different types of PH, and overview of treatments. In addition, it emphasizes the importance of early referral to, and partnership between, PH specialists and physicians on the front lines to improve early diagnosis and optimize management of these complex patients.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical presentation; Diagnostic algorithm; Pulmonary arterial hypertension; Pulmonary hypertension; Treatment

Mesh:

Year:  2019        PMID: 30955510     DOI: 10.1016/j.mcna.2018.12.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  17 in total

1.  Compartmentalization of Redox-Regulated Signaling in the Pulmonary Circulation.

Authors:  Stephen M Black; Eva Nozik-Grayck
Journal:  Antioxid Redox Signal       Date:  2019-07-03       Impact factor: 8.401

2.  Ethosome-Derived Invasomes as a Potential Transdermal Delivery System for Vardenafil Hydrochloride: Development, Optimization and Application of Physiologically Based Pharmacokinetic Modeling in Adults and Geriatrics.

Authors:  Hussein O Ammar; Mina Ibrahim Tadros; Nahla M Salama; Amira Mohsen Ghoneim
Journal:  Int J Nanomedicine       Date:  2020-08-06

Review 3.  The roles of microRNAs played in lung diseases via regulating cell apoptosis.

Authors:  Qiaoling Huang; Li Chen; Qinqin Bai; Ting Tong; You Zhou; Zhongyu Li; Chunxue Lu; Shenghua Chen; Lili Chen
Journal:  Mol Cell Biochem       Date:  2021-08-16       Impact factor: 3.396

Review 4.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

5.  Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis.

Authors:  Xiaogang Jing; Shujun Wu; Ying Liu; Huan Wang; QingFeng Huang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Protein expression profile changes of lung tissue in patients with pulmonary hypertension.

Authors:  Min Wu; Yijin Wu; Jinsong Huang; Yueheng Wu; Hongmei Wu; Benyuan Jiang; Jian Zhuang
Journal:  PeerJ       Date:  2020-01-31       Impact factor: 2.984

7.  Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study.

Authors:  Yuka Takita; Yuko Takeda; Daisuke Fujisawa; Masaharu Kataoka; Takashi Kawakami; Ardith Z Doorenbos
Journal:  BMJ Open Respir Res       Date:  2021-04

8.  eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.

Authors:  Linya Guo; Yanbing Li; Ying Tian; Shaoxin Gong; Xi Chen; Tianhong Peng; Aiping Wang; Zhisheng Jiang
Journal:  Drug Des Devel Ther       Date:  2019-08-13       Impact factor: 4.162

Review 9.  Endoplasmic reticulum stress and pulmonary hypertension.

Authors:  Yanan Hu; Wenhao Yang; Liang Xie; Tao Liu; Hanmin Liu; Bin Liu
Journal:  Pulm Circ       Date:  2020-02-04       Impact factor: 3.017

10.  Midterm postoperative prognosis of patients with severe left heart valvular disease combined with moderate or severe pulmonary hypertension treated with treprostinil.

Authors:  Ning Xu; Shu-Ting Huang; Kai-Peng Sun; Zeng-Chun Wang; Hua Cao; Qiang Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-11-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.